Open access · OA
via OpenAlex
At the crossroads of longevity and metabolism: the metabolic syndrome and lifespan determinant pathways
Gian Paolo Fadini, Giulio Ceolotto, Elisa Pagnin, Saula de Kreutzenberg, Angelo Avogaro
Aging Cell · 2010 · ▲ 97 citations
Deregulated nutrient-sensing
Altered intercellular communication
Rapamycin / mTOR inhibition
Human
Mouse
Abstract
The metabolic syndrome is becoming increasingly prevalent in the general population and carries significant incremental morbidity and mortality. It is associated with multi-organ involvement and increased all-cause mortality, resembling a precocious aging process. The mechanisms that account for this phenomenon are incompletely known, but it is becoming clear that longevity genes might be involved. Experiments with overactivation or disruption of key lifespan determinant pathways, such as silent information regulator (SIR)T1, p66Shc, and mammalian target of mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) (TOR), lead to development of features of the metabolic syndrome in mice. These genes integrate longevity pathways and metabolic signals in a complex interplay in which lifespan appears to be strictly dependent on substrate and energy bioavailability. Herein, we describe the roles and possible interconnections of selected lifespan determinant molecular networks in the development of the metabolic syndrome and its complications, describing initial available data in humans. Additional pathways are involved in linking nutrient availability and longevity, certainly including insulin and Insulin-like Growth Factor-1 (IGF-1) signaling, as well as FOXO transcription factors. The model described in this viewpoint article is therefore likely to be an oversimplification. Nevertheless, it represents one starting platform for understanding cell biology of lifespan in relation to the metabolic syndrome.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1111/j.1474-9726.2010.00642.x
- Canonical
- link ↗
- Fetched
- 2026-10-22 MST
Cite this
APA
Fadini, G.P., Ceolotto, G., Pagnin, E., Kreutzenberg, S.D., & Avogaro, A. (2010). At the crossroads of longevity and metabolism: the metabolic syndrome and lifespan determinant pathways. <em>Aging Cell</em>. https://doi.org/10.1111/j.1474-9726.2010.00642.x
Vancouver
Fadini GP, Ceolotto G, Pagnin E, Kreutzenberg SD, Avogaro A. At the crossroads of longevity and metabolism: the metabolic syndrome and lifespan determinant pathways. Aging Cell. 2010. doi:10.1111/j.1474-9726.2010.00642.x.
BibTeX
@article{gian2010Atthec,
title = {At the crossroads of longevity and metabolism: the metabolic syndrome and lifespan determinant pathways},
author = {Gian Paolo Fadini and Giulio Ceolotto and Elisa Pagnin and Saula de Kreutzenberg and Angelo Avogaro},
journal = {Aging Cell},
year = {2010},
doi = {10.1111/j.1474-9726.2010.00642.x},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
International Journal of Molecular Sciences 2022
Open access · CC-BY
Drosophila as a Model Organism to Study Basic Mechanisms of Longevity
PubMed 2009
Preprint
[The mechanisms whereby insulin/IGF-1 signaling regulates aging and longevity].
PubMed 2009
Preprint
[The mechanisms whereby insulin/IGF-1 signaling regulates aging and longevity].
Hormone and Metabolic Research 2025
Citation only
Thyroid Hormones and Aging: Modulators of Mitochondrial Health, Metabolic Flexibility, and Longevity Pathways
Nature Communications 2022
Open access · CC-BY
Interaction of a viral insulin-like peptide with the IGF-1 receptor produces a natural antagonist
Journal of cosmetic dermatology 2026
Open access · OA